Drug Information

Drug General Information
Drug ID
D00GCA
Former ID
DNCL003142
Drug Name
MK-7288
Indication Excessive daytime sleepiness [ICD9: 291.82, 292.85, 307.43-307.44, 327.1, 780.53-780.54; ICD10:F51.1, G47.1] Phase 1 [522986]
Company
Merck
Target and Pathway
Target(s) Histamine H3 receptor Target Info Agonist [532509]
KEGG Pathway Neuroactive ligand-receptor interaction
Reactome Histamine receptors
G alpha (i) signalling events
WikiPathways Monoamine Transport
GPCRs, Class A Rhodopsin-like
GPCR ligand binding
GPCR downstream signaling
References
Ref 522986ClinicalTrials.gov (NCT01092780) Pharmacodynamics and Efficacy of MK7288 (MK-7288-010). U.S. National Institutes of Health.
Ref 532509Early-stage comparative effectiveness: randomized controlled trial with histamine inverse agonist MK-7288 in excessive daytime sleepiness patients. J Clin Pharmacol. 2013 Dec;53(12):1294-302.

If you find any error in data or bug in web service, please kindly report it to Dr. Tang and Dr. Mou.